Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia.

Gajanayake, T; Sawitzki, B; Matozan, K; Korchagina, E Y; Lehmann, M; Volk, H-D; Rieben, R

Gajanayake, T; Sawitzki, B; Matozan, K; Korchagina, E Y; Lehmann, M; Volk, H-D; Rieben, R.

Affiliation

Gajanayake T; Department of Clinical Research, University of Bern, Bern, Switzerland.

Am J Transplant ; 8(6): 1151-62, 2008 Jun.

Article in En | MEDLINE | ID: mdl-18444916

Subject(s)

Antibodies, Monoclonal/therapeutic use; Dextran Sulfate/therapeutic use; Graft Survival/drug effects; Heart Transplantation; Immunologic Factors/therapeutic use; Reperfusion Injury/immunology; Animals; Antibodies, Monoclonal/immunology; CD4 Antigens; CD4-Positive T-Lymphocytes; Cold Ischemia/adverse effects; Disease Models, Animal; Graft Survival/immunology; Immunity, Innate; Male; Rats; Rats, Inbred Strains; Reperfusion Injury/etiology; Transplantation Tolerance/drug effects; Transplantation Tolerance/immunology; Transplantation, Homologous

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Reperfusion Injury / Dextran Sulfate / Heart Transplantation / Graft Survival / Immunologic Factors / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google